Crown Holdings, Inc. (NYSE:CCK) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Crown Holdings, Inc. (NYSE:CCK) has been assigned a consensus recommendation of “Moderate Buy” from the fifteen analysts that are covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $118.9231.

A number of equities analysts recently weighed in on the stock. Royal Bank Of Canada boosted their price target on shares of Crown from $116.00 to $120.00 and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Raymond James Financial reiterated an “outperform” rating and issued a $115.00 target price (up from $110.00) on shares of Crown in a research note on Wednesday, October 22nd. Truist Financial increased their target price on shares of Crown from $126.00 to $130.00 and gave the company a “buy” rating in a research report on Tuesday, January 6th. Mizuho lifted their price target on shares of Crown from $116.00 to $120.00 and gave the stock an “outperform” rating in a report on Tuesday, October 21st. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Crown in a research note on Monday, December 29th.

Crown Price Performance

Shares of NYSE CCK opened at $104.47 on Monday. The company has a market capitalization of $12.05 billion, a PE ratio of 12.93, a PEG ratio of 1.20 and a beta of 0.75. The company has a quick ratio of 0.76, a current ratio of 1.16 and a debt-to-equity ratio of 1.65. The stock’s 50 day moving average price is $99.55 and its 200-day moving average price is $99.30. Crown has a twelve month low of $75.98 and a twelve month high of $109.48.

Crown (NYSE:CCK) last issued its quarterly earnings results on Monday, October 20th. The industrial products company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $1.98 by $0.26. The business had revenue of $3.20 billion for the quarter, compared to analyst estimates of $3.13 billion. Crown had a return on equity of 26.86% and a net margin of 7.79%.Crown’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period last year, the company posted $1.99 earnings per share. Crown has set its Q4 2025 guidance at 1.650-1.75 EPS and its FY 2025 guidance at 7.700-7.80 EPS. On average, equities analysts anticipate that Crown will post 6.96 EPS for the current year.

Crown Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, November 20th. Stockholders of record on Thursday, November 6th were paid a dividend of $0.26 per share. The ex-dividend date was Thursday, November 6th. This represents a $1.04 annualized dividend and a dividend yield of 1.0%. Crown’s dividend payout ratio is presently 12.87%.

Insider Transactions at Crown

In other news, COO Djalma Novaes, Jr. sold 19,754 shares of Crown stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $101.02, for a total value of $1,995,549.08. Following the completion of the transaction, the chief operating officer owned 96,841 shares in the company, valued at $9,782,877.82. This trade represents a 16.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Timothy J. Donahue sold 8,476 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $105.01, for a total transaction of $890,064.76. Following the sale, the chief executive officer owned 440,580 shares in the company, valued at $46,265,305.80. The trade was a 1.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Crown

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Farther Finance Advisors LLC raised its stake in shares of Crown by 19.7% during the second quarter. Farther Finance Advisors LLC now owns 633 shares of the industrial products company’s stock valued at $65,000 after acquiring an additional 104 shares in the last quarter. Geneos Wealth Management Inc. grew its stake in Crown by 45.3% in the first quarter. Geneos Wealth Management Inc. now owns 356 shares of the industrial products company’s stock worth $32,000 after purchasing an additional 111 shares in the last quarter. ProShare Advisors LLC increased its holdings in Crown by 2.3% during the 2nd quarter. ProShare Advisors LLC now owns 5,101 shares of the industrial products company’s stock worth $525,000 after purchasing an additional 113 shares during the period. DekaBank Deutsche Girozentrale raised its position in Crown by 1.2% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 9,477 shares of the industrial products company’s stock valued at $983,000 after purchasing an additional 114 shares in the last quarter. Finally, Siemens Fonds Invest GmbH lifted its holdings in shares of Crown by 7.7% in the 3rd quarter. Siemens Fonds Invest GmbH now owns 1,626 shares of the industrial products company’s stock worth $157,000 after buying an additional 116 shares during the period. Institutional investors own 90.93% of the company’s stock.

About Crown

Crown Holdings, Inc is a leading global supplier of rigid packaging products for consumer goods markets. The company designs, manufactures and sells metal packaging for beverage, food, household, personal care and specialty products. Its portfolio includes aluminum and steel beverage cans, steel food cans, aluminum aerosols, metal closures and ends, offering customers end-to-end solutions from design and prototyping to large-scale production.

Founded in 1919 as the Crown Cork & Seal Company, Crown has grown through strategic acquisitions and investments in advanced manufacturing technologies.